✦ LIBER ✦
Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in HBEAG-negative and -positive patients with chronic hepatitis B who have failed prior lamivudine therapy
✍ Scribed by R. Gish; T.T. Chang; S. Hadziyannis; J. Cianciara; M. Rizzetto; E. Schiff; G. Pastore; K. Klesczewski; G. Densiky; J. Zhu; D. DeHertogh; R. Hindes
- Book ID
- 117372417
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 316 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.